This chapter explores the motivations behind pharmaceutical companies' innovations in drug delivery, focusing on the transition from injections to pill forms for weight loss and diabetes treatments. It discusses the competitive landscape among major companies and examines potential future applications for these new drug forms.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.